Prolonged response to recombinant human erythropoietin treatment in patients with myelodysplastic syndrome at a single referral centre in Brazil

OBJECTIVES: To evaluate the effects of epoetin (EPO) alfa treatment on overall survival, event-free survival and response duration in patients with myelodysplastic syndrome (MDS) who were treated at a haematological referral centre in northeastern Brazil. METHODS: This was a retrospective cohort st...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Anna Thawanny Gadelha Moura, Fernando Barroso Duarte, Maritza Cavalcante Barbosa, Talyta Ellen de Jesus dos Santos, Romélia Pinheiro Gonçalves Lemes
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier España
Saila:	Clinics
Gaiak:	Myelodysplastic Syndrome Recombinant Human Erythropoietin Erythropoietin Epoetin Alfa EPO EPO Alfa
Sarrera elektronikoa:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322019000100263&lng=en&tlng=en
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!